Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Different Regimens of Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion: a Randomized and Controlled Clinical Study.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04062370
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:11.306414+00:00
Published At
2019-08-20T00:00:00+00:00
Record Updated At
2019-08-20
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Retinal Vein Occlusion", "Treatment", "Photocoagulation Burn to Retina", "Ranibizumab"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-08-20"
protocolSection.identificationModule.nctId
"NCT04062370"
protocolSection.identificationModule.officialTitle
"Different Regimens of Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion: a Randomized and Controlled Clinical Study."
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Retinal Vein Occlusion (protocolSection.conditionsModule.conditions)
  • Treatment (protocolSection.conditionsModule.conditions)
  • Photocoagulation Burn to Retina (protocolSection.conditionsModule.conditions)
  • Ranibizumab (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.